BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11890230)

  • 21. Desmopressin for nocturnal enuresis: urinary osmolality and response.
    Folwell AJ; Macdiarmid SA; Crowder HJ; Lord AD; Arnold EP
    Br J Urol; 1997 Sep; 80(3):480-4. PubMed ID: 9313673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical perspectives in primary nocturnal enuresis.
    Gimpel GA; Warzak WJ; Kuhn BR; Walburn JN
    Clin Pediatr (Phila); 1998 Jan; 37(1):23-9. PubMed ID: 9475696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy, safety, and dosing of desmopressin for nocturnal enuresis in Europe.
    Hjälmås K; Bengtsson B
    Clin Pediatr (Phila); 1993 Jul; Spec No():19-24. PubMed ID: 8039334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cure of nocturnal enuresis: why isn't desmopressin very effective?
    Koff SA
    Pediatr Nephrol; 1996 Oct; 10(5):667-70. PubMed ID: 8897581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasopressin and hypercalciuria in enuresis: a reappraisal.
    Nevéus T; Hansell P; Stenberg A
    BJU Int; 2002 Nov; 90(7):725-9. PubMed ID: 12410756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy for nocturnal enuresis with desmopressin and an alarm device.
    Bradbury M
    Scand J Urol Nephrol Suppl; 1997; 183():61-3. PubMed ID: 9165611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy concept in enuretic children.
    Etele-Hainz A; Artens E; Marberger M
    Eur Urol; 1998; 33 Suppl 3():49-52. PubMed ID: 9599739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of oral desmopressin in the treatment of primary nocturnal enuresis in Asian children.
    Yap HK; Chao SM; Tan AY; Murugasu B; Ong EK; Low EH
    J Paediatr Child Health; 1998 Apr; 34(2):151-3. PubMed ID: 9588639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary nocturnal enuresis and desmopressin treatment: do psychosocial factors affect outcome?
    Dittmann RW; Wolter S
    Eur Child Adolesc Psychiatry; 1996 Jun; 5(2):101-9. PubMed ID: 8814416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Desmopressin (DDAVP) for enuresis, diabetes insipidus, and..
    Gaines KK
    Urol Nurs; 2004 Dec; 24(6):520-3. PubMed ID: 15658741
    [No Abstract]   [Full Text] [Related]  

  • 31. The evaluation of desmopressin in treatment of adolescent nocturnal enuresis.
    Derman O; Kanbur NO; Kinik E
    Int J Adolesc Med Health; 2004; 16(4):377-85. PubMed ID: 15712975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desmopressin in nocturnal enuresis.
    Aladjem M; Wohl R; Boichis H; Orda S; Lotan D; Freedman S
    Arch Dis Child; 1982 Feb; 57(2):137-40. PubMed ID: 7039520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daytime functional bladder capacity as a predictor of response to desmopressin in monosymptomatic nocturnal enuresis.
    Eller DA; Austin PF; Tanguay S; Homsy YL
    Eur Urol; 1998; 33 Suppl 3():25-9. PubMed ID: 9599733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary nocturnal enuresis in children. Background and treatment.
    Wille S
    Scand J Urol Nephrol Suppl; 1994; 156():1-48. PubMed ID: 7939438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Canadian Enuresis Study and Evaluation--short- and long-term safety and efficacy of an oral desmopressin preparation.
    Wolfish NM; Barkin J; Gorodzinsky F; Schwarz R
    Scand J Urol Nephrol; 2003; 37(1):22-7. PubMed ID: 12745738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional bladder capacity as predictor of response to desmopressin and retention control training in monosymptomatic nocturnal enuresis.
    Hamano S; Yamanishi T; Igarashi T; Ito H; Murakami S
    Eur Urol; 2000 Jun; 37(6):718-22. PubMed ID: 10828674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic factors as predictors for desmopressin treatment success.
    Hogg RJ
    Scand J Urol Nephrol Suppl; 1997; 183():37-9. PubMed ID: 9165604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis.
    Vande Walle JG; Bogaert GA; Mattsson S; Schurmans T; Hoebeke P; Deboe V; Norgaard JP;
    BJU Int; 2006 Mar; 97(3):603-9. PubMed ID: 16469035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the best treatment for nocturnal enuresis in children?
    Lyon C; Schnall J
    J Fam Pract; 2005 Oct; 54(10):905-6, 909. PubMed ID: 16202382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spot urine osmolality, age and bladder capacity as predictors of response to desmopressin in nocturnal enuresis.
    Eller DA; Homsy YL; Austin PF; Tanguay S; Cantor A
    Scand J Urol Nephrol Suppl; 1997; 183():41-5. PubMed ID: 9165605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.